This website uses cookies to enhance your browsing experience. By continuing to browse this website, you agree to accept our use of cookies. For more information, please review our Privacy Policy.
ADLARITY® is the first and only FDA-approved once-weekly transdermal system that consistently delivers donepezil while it's worn.
Not actual size.
ADLARITY® is the first and only FDA-approved once-weekly transdermal system that consistently delivers donepezil while it's worn.
Not actual size.
ADLARITY is not a daily pill. It is a once-weekly donepezil transdermal system.
Discover ADLARITYADLARITY is applied to the skin. See how it is done.
Learn moreLearn about access and coverage for ADLARITY.
Explore optionsHere is a helpful video to get started with ADLARITY
Do not take ADLARITY if you:
Do not take ADLARITY if you:
Tell your doctor about all of your present or past health conditions, including:
Tell your doctor about all the medicines you take, including prescription and non-prescription medicines, vitamins, and herbal products. ADLARITY and other medicines may affect each other when used at the same time. Especially tell your healthcare provider if you take medicines called nonsteroidal anti-inflammatory drugs (NSAIDs).
Tell your healthcare provider or dentist that you use the ADLARITY transdermal system before you have surgery, medical procedures, or dental surgery or procedures.
The most common side effects of ADLARITY (>3%) were headache (15%), application site itching (9%), muscle spasms (9%), sleeplessness (7%), abdominal pain (5%), application site skin irritation (6%), constipation (5%), diarrhea (4%), application site pain (4%), dizziness (4%), abnormal dreams (4%), and skin tearing (4%).
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/MedWatch or call 1‑800‑FDA‑1088.
Please click here for Full Prescribing Information and Patient Information.